Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031857 |
---|---|
Receipt number | R000036377 |
Scientific Title | A multi-center proof-of-concept phase2 study of encorafenib + binimetinib + cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer |
Date of disclosure of the study information | 2018/04/01 |
Last modified on | 2023/07/21 13:45:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/03/23 12:03:04 | ||
2 | Update | 2018/09/19 08:38:30 | Recruitment status |
|
3 | Update | 2018/10/05 11:06:24 | Institutions |
|
4 | Update | 2023/07/21 13:45:40 | Recruitment status Date of IRB Last follow-up date |